Abstract:Abstract: Studies of processing of the Alzheimer β‐amyloid precursor protein (βAPP) have been performed to date mostly in continuous cell lines and indicate the existence of two principal metabolic pathways: the “β‐secretase” pathway, which generates β‐amyloid (Aβ1–40/42; ∼4 kDa), and the “α‐secretase” pathway, which generates a smaller fragment, the “p3” peptide (Aβ17–40/42; ∼3 kDa). To determine whether similar processing events underlie βAPP metabolism in neurons, media were examined following conditioning by primary neuronal cultures derived from embryonic day 17 rats. Immunoprecipitates of conditioned media derived from [35S]methionine pulse‐labeled primary neuronal cultures contained 4‐ and 3‐kDa Aβ‐related species. Radiosequencing analysis revealed that the 4‐kDa band corresponded to conventional Aβ beginning at position Aβ(Asp1), whereas both radio‐sequencing and immunoprecipitation‐mass spectrometry analyses indicated that the 3‐kDa species in these conditioned media began with Aβ(Glu11) at the N terminus, rather than Aβ(Leu17) as does the conventional p3 peptide. Either activation of protein kinase C or inhibition of protein phosphatase 1/2A increased soluble βAPPα release and decreased generation of both the 4‐kDa Aβ and the 3‐kDa N‐truncated Aβ. Unlike results obtained with continuously cultured cells, protein phosphatase 1/2A inhibitors were more potent at reducing Aβ secretion by neurons than were protein kinase C activators. These data indicate that rodent neurons generate abundant Aβ variant peptides and emphasize the role of protein phosphatases in modulating neuronal Aβ generation.

Generation and Regulation of Β‐amyloid Peptide Variants by Neurons

Endoplasmic Reticulum and Trans-Golgi Network Generate Distinct Populations of Alzheimer Beta-Amyloid Peptides

Generation of the Amyloid-β Peptide N Terminus Insaccharomyces Cerevisiae Expressing Human Alzheimer's Amyloid-β Precursor Protein

Cellular and Molecular Basis of Beta-Amyloid Precursor Protein Metabolism

Amyloid Precursor Protein Revisited: NEURON-SPECIFIC EXPRESSION AND HIGHLY STABLE NATURE OF SOLUBLE DERIVATIVES

Differential release of β-amyloid from dendrite- versus axon-targeted APP.

Generation of Alzheimer Beta-Amyloid Protein in the Trans-Golgi Network in the Apparent Absence of Vesicle Formation

Amyloid Precursor Protein Revisited

Metabolism Of Alzheimer Beta-Amyloid Precursor Protein: Regulation By Protein Kinase A In Intact Cells And In A Cell-Free System

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

Proteolytic processing of Alzheimer's β-amyloid precursor protein.

Genetic Background Regulates Beta-Amyloid Precursor Protein Processing and Beta-Amyloid Deposition in the Mouse

Generation of the Amyloid-Beta Peptide N Terminus in Saccharomyces Cerevisiae Expressing Human Alzheimer'S Amyloid-Beta Precursor Protein

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Aβ-mediated neurotoxicity: Microglia-mediated oxidative neurotoxicity

Neuritogenic-Neurotoxic Effects of Membrane-Associated Forms ofAmyloid Precursor Prot ein

APP Substitutions V715F and L720P Alter PS1 Conformation and Differentially Affect Abeta and AICD Generation.

Γ-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid Β Peptides of Varying Length

CELLULAR AND MOLECULAR BASIS OF Β-Amyloid PRECURSOR PROTEIN METABOLISM

Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes

Proteolysis of Chimeric β-Amyloid Precursor Proteins Containing the Notch Transmembrane Domain Yields Amyloid β-like Peptides

Regulation of β cleavage of amyloid precursor protein